Sign in
Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2021
Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
2020
The Impact of Image Processing Algorithms on Quantitative Optical Coherence Tomography Angiography Metrics in Diabetic Retinopathy
Jay C Wang, MD
Category: Diabetic Retinopathy